Mr. Chris Younger reports

ABERDEEN DISPOSES OF SHARES OF MEDIVOLVE AND CEASES TO BE AN INSIDER

Aberdeen International Inc. sold seven million common shares of Medivolve Inc. on Sept. 22, 2022, which has resulted in Aberdeen's ownership being reduced by 1.7 per cent to less than 10 per cent of the outstanding Medivolve common shares and Aberdeen ceasing to be an insider of Medivolve.

The company reviews its holdings from time to time and may increase or decrease its position as future circumstances may dictate.

This news release is being issued in accordance with National Instrument 62-103 -- The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the filing of an early warning report dated Sept. 29, 2022. The early warning report respecting the occurrence giving rise to this filing has been filed on SEDAR under Medivolve's issuer profile.

About Aberdeen International Inc.

Aberdeen International is a global resource investment company and merchant bank focused on small capitalization companies in the rare metals and renewable energy sectors. Progressus Clean Technologies (formerly AES-100 Inc.), an Aberdeen portfolio investment, owns the exclusive rights and all intellectual property pertaining to the advanced electrolyzer system for the production of hydrogen from dilute syngas.

We seek Safe Harbor.